Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangxi Baoruitan Pharmaceutical
Nanning, Guangxi, Chinabaoruitan.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Guangxi Baoruitan Pharmaceutical is a specialized pharmaceutical company based in Nanning, China, focused on the development and production of dermatological treatments. The company is primarily recognized for its flagship product, Imiquimod cream, which is used as an immune response modifier for conditions such as external genital warts and certain skin cancers. Baoruitan operates modern, GMP-certified manufacturing facilities dedicated to topical formulations and small molecule synthesis. As a recognized high-tech enterprise, the company integrates research, production, and sales to serve the domestic Chinese healthcare market.
- Therapeutic areas
- OncologyDermatologyInfectious Diseases
- Modalities
- Small molecule
- Industry
- Biotech
Beyond the preview
Go deeper on Guangxi Baoruitan Pharmaceutical.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Guangxi Baoruitan Pharmaceutical.